期刊文献+
共找到924篇文章
< 1 2 47 >
每页显示 20 50 100
MicroRNA-298 determines the radio-resistance of colorectal cancer cells by directly targeting human dual-specificity tyrosine(Y)-regulated kinase 1A
1
作者 Mei-Zhu Shen Yong Zhang +6 位作者 Fang Wu Mei-Zhen Shen Jun-Lin Liang Xiao-Long Zhang Xiao-Jian Liu Xin-Shu Li Ren-Sheng Wang 《World Journal of Gastrointestinal Oncology》 SCIE 2024年第4期1453-1464,共12页
BACKGROUND Radiotherapy stands as a promising therapeutic modality for colorectal cancer(CRC);yet,the formidable challenge posed by radio-resistance significantly undermines its efficacy in achieving CRC remission.AIM... BACKGROUND Radiotherapy stands as a promising therapeutic modality for colorectal cancer(CRC);yet,the formidable challenge posed by radio-resistance significantly undermines its efficacy in achieving CRC remission.AIM To elucidate the role played by microRNA-298(miR-298)in CRC radio-resistance.METHODS To establish a radio-resistant CRC cell line,HT-29 cells underwent exposure to 5 gray ionizing radiation that was followed by a 7-d recovery period.The quantification of miR-298 levels within CRC cells was conducted through quantitative RT-PCR,and protein expression determination was realized through Western blotting.Cell viability was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and proliferation by clonogenic assay.Radio-induced apoptosis was discerned through flow cytometry analysis.RESULTS We observed a marked upregulation of miR-298 in radio-resistant CRC cells.MiR-298 emerged as a key determinant of cell survival following radiation exposure,as its overexpression led to a notable reduction in radiation-induced apoptosis.Intriguingly,miR-298 expression exhibited a strong correlation with CRC cell viability.Further investigation unveiled human dual-specificity tyrosine(Y)-regulated kinase 1A(DYRK1A)as miR-298’s direct target.CONCLUSION Taken together,our findings underline the role played by miR-298 in bolstering radio-resistance in CRC cells by means of DYRK1A downregulation,thereby positioning miR-298 as a promising candidate for mitigating radioresistance in CRC. 展开更多
关键词 MicroRNA-298 Human dual-specificity tyrosine(Y)-regulated kinase 1A Colorectal cancer Radio-resistance p53 binding protein 1
下载PDF
EFFECT OF ACTIVE COMPOUNDS ISOLATED FROM PTERIS SEMIPINNATA L ON DNA TOPOISOMERASES AND TYROSINE PROTEIN KINASE AND EXPRESSION OF C-MYC IN LUNG ADENOCARCINOMA CELLS 被引量:1
2
作者 李金华 梁念慈 +2 位作者 莫丽儿 张晓 何承伟 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2001年第2期105-109,共5页
Objective: To study the effect of active compound 6F and A from Pteris semipinnata L.(PsL) on the activities of DNA topoisomerase (TOPO) I and II, activities of cytosolic and membrane TPK, and expression of oncogene c... Objective: To study the effect of active compound 6F and A from Pteris semipinnata L.(PsL) on the activities of DNA topoisomerase (TOPO) I and II, activities of cytosolic and membrane TPK, and expression of oncogene c-myc in lung adenocarcinoma cells. Methods: The effect of compound 6F and A on activities of cytosolic and membrane TPK was measured by scintillation counting; the effect of compound A on expression of oncogene c-myc was determined by flow cytometry indirect fluorimetry. Results: compound 6F and A could inhibit the activities of TOPO I, and they strongly inhibited the TOPO II in 0.01 mg/L and 10.0 mg/L respectively. Compound A slightly inhibited the activities of membrane TPK, but not the cytosolic one. Compound A could inhibit the expression of oncogene c-myc. Conclusion: Topoisomerases are target of compound 6F and A. Compound A could slightly inhibit the activities of TPK, and showed an inhibitory effect on the expression of oncogene c-myc. 展开更多
关键词 Pteris semipinnata L. DNA topoisomerase 酷氨酸蛋白质 kinase C-MYC
下载PDF
ABNORMAL PROTEIN TYROSINE KINASES ASSOCIATED WITH HUMAN HAEMATOLOGICAL MALIGNANCIES
3
作者 孙雪梅 Graham J Lieschke 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2002年第2期79-83,共5页
Objective: To survey the role of protein tyrosine kinases (PTKs) in the pathogenesis of several hematopoietic malignancies. Methods: By reviewing the published laboratory and clinical studies on PTK-related oncoprotei... Objective: To survey the role of protein tyrosine kinases (PTKs) in the pathogenesis of several hematopoietic malignancies. Methods: By reviewing the published laboratory and clinical studies on PTK-related oncoproteins and their causative role in some leukemias and lymphomas. Results: Protein tyrosine kinases are key participants in signal transduction pathways that regulate cellular growth, activation and differentiations. Aberrant PTK activity resulting from gene mutation (often accompanying chromosome translocation) plays an etiologic role in several clonal hematopoietic malignancies. For example, the PTK product of the BCR-ABL fusion gene resulting from the t (9; 22) translocation exhibits several fold higher tyrosine kinase activity than the product of the ABL gene. Evidence suggests that the BCR-ABL oncoprotein alone is sufficient to case chronic myelogenous leukemia (CML) and other Ph positive acute leukemia. PTK over-activity resulting from chromosomal translocations creating TEL-ABL, TEL-JAK2 and TEL-PDGFRb fusion proteins plays an important role in the pathogenesis of other types of leukemia. Another example occurs in anaplastic large cell lymphoma (ALCL). Experimental and clinical evidences indicate that translocations involving ALK gene on chromosome 2p23, most commonly resulting in an NPM-ALK fusion oncogene, result in constitutive activation of ALK and cause ALCL. This group of lymphomas is now named ALK positive lymphoma or ALKoma. Conclusion: Genetic lesions creating aberrant fusion proteins that result in excessive PTK activity are increasingly being recognized as central to the pathogenesis of hemotopoietic malignancies. These chimeric PTK molecules represent attractive disease-specific targets against which new classes therapeutic agents are being developed. 展开更多
关键词 protein tyrosine kinase (PTK) Hematopoietic malignancy BCR-ABL Chronic MYELOGENOUS leukemia (CML) ANAPLASTIC large cell lymphoma (ALCL) STI 571 protein tyrosine kinase inhibitor
下载PDF
Effects of insulin receptor tyrosine protein kinase on insulin resistance after scalding in rats
4
作者 毛旭虎 许霖水 《Journal of Medical Colleges of PLA(China)》 CAS 1996年第4期290-293,共4页
Effectsofinsulinreceptortyrosineproteinkinaseoninsulinresistanceafterscaldinginrats¥(毛旭虎)(许霖水)MaoXuhu,XuLins... Effectsofinsulinreceptortyrosineproteinkinaseoninsulinresistanceafterscaldinginrats¥(毛旭虎)(许霖水)MaoXuhu,XuLinshui(DepartmentofB... 展开更多
关键词 SCALDING INSULIN RECEPTOR tyrosine protein kinase INSULIN resistance rats
下载PDF
Modulation of protein tyrosine phosphorylation in gastric mucosa during re-epithelization processes 被引量:2
5
作者 Olena V Bogdanova Larysa I Kot +4 位作者 Kateryna V Lavrova Volodymyr B Bogdanov Erica K Sloan Tetyana V Beregova Ludmyla I Ostapchenko 《World Journal of Biological Chemistry》 CAS 2010年第11期338-347,共10页
AIM:To investigate the role of protein tyrosine phosphorylation in gastric wound formation and repair following ulceration. METHODS:Gastric lesions were induced in rats using restraint cold stress.To investigate the e... AIM:To investigate the role of protein tyrosine phosphorylation in gastric wound formation and repair following ulceration. METHODS:Gastric lesions were induced in rats using restraint cold stress.To investigate the effect of oxidative and nitrosative cell stress on tyrosine phosphorylation during wound repair,total activity of protein tyrosine kinase(PTK),protein tyrosine phosphatase (PTP),antioxidant enzymes,nitric oxide synthase (NOS), 2',5'-oligoadenylate synthetase,hydroxyl radical and zinc levels were assayed in parallel. RESULTS:Ulcer provocation induced an immediate decrease in tyrosine kinase(40% in plasma membranes and 56% in cytosol,(P<0.05) and phosphatase activity (threefold in plasma membranes and 3.3-fold in cytosol),followed by 2.3-2.4-fold decrease (P<0.05) in protein phosphotyrosine content in the gastric mucosa. Ulceration induced no immediate change in superoxide dismutase (SOD) activity,30% increase (P<0.05) in catalase activity,2.3-fold inhibition (P<0.05) of glutathione peroxidase,3.3-fold increase (P<0.05) in hydroxyl radical content,and 2.3-fold decrease (P<0.05) in zinc level in gastric mucosa.NOS activity was three times higher in gastric mucosa cells after cold stress. Following ulceration,PTK activity increased in plasma membranes and reached a maximum on day 4 after stress (twofold increase,P<0.05),but remained inhibited(1.6-3-fold decrease on days 3,4 and 5,P<0.05) in the cytosol.Tyrosine phosphatases remained inhibited both in membranes and cytosol(1.5-2.4-fold,P< 0.05).NOS activity remained increased on days 1,2 and 3(3.8-,2.6-,2.2-fold,respectively,P<0.05).Activity of SOD increased 1.6 times(P<0.05)days 4 and 5 after stress.Catalase activity normalized after day 2. Glutathione peroxidase activity and zinc level decreased (3.3-and 2-fold,respectively,P<0.05)on the last day. Activity of 2',5'-oligoadenylate synthethase increased 2.8-fold (P<0.05) at the beginning,and 1.6-2.3-fold (P<0.05) during ulcer recuperation,and normalized on day 5,consistent with slowing of inflammation processes. CONCLUSION:These studies show diverse changes in total tyrosine kinase activity in gastric mucosa during the recovery process.Oxidative and nitrosative stress during lesion formation might lead to the observed reduction in tyrosine phosphorylation during ulceration. 展开更多
关键词 protein tyrosine kinase protein tyrosine PHOSPHATASE ANTIOXIDANTS Gastric ULCER Wound repair
下载PDF
Protein tyrosine phosphatase 1B regulates migration of ARPE-19 cells through EGFR/ERK signaling pathway 被引量:3
6
作者 Zhao-Dong Du Li-Ting Hu +4 位作者 Gui-Qiu Zhao Qian Wang Qiang Xu Nan Jiang Jing Lin 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2015年第5期891-897,共7页
AIM: To evaluate whether protein tyrosine phosphatase1B(PTP1B) contributed to initiate human retinal pigment epithelium cells(ARPE)-19 migration and investigate the signaling pathways involved in this process.·ME... AIM: To evaluate whether protein tyrosine phosphatase1B(PTP1B) contributed to initiate human retinal pigment epithelium cells(ARPE)-19 migration and investigate the signaling pathways involved in this process.·METHODS: ARPE-19 cells were cultured and treated with the si RNA-PTP1 B. Expression of PTP1 B was confirmed by quantitative reverse transcriptase-polymerase chain reaction(q RT-PCR). AG1478 [a selective inhibitor of epidermal growth factor receptor(EGFR)] and PD98059(a specific inhibitor of the activation of mitogen-activated protein kinase) were used to help to determine the PTP1 B signaling mechanism.Western blot analysis verified expression of EGFR and extracellular signal-regulated kinase(ERK) in ARPE-19 cells. The effect of si RNA-PTP1 B on cell differentiation was confirmed by immunostaining for α-smooth muscle actin(α-SMA) and q RT-PCR. Cell migration ability was analyzed by transwell chamber assay.·RESULTS: The m RNA levels of PTP1 B were reduced by si RNA-PTP1 B as determined by q RT-PCR assay.Si RNA-PTP1 B activated EGFR and ERK phosphorylation.α-SMA staining and q RT-PCR assay demonstrated that si RNA-PTP1 B induced retinal pigment epithelium(RPE)cells to differentiate toward better contractility and motility. Transwell chamber assay proved that PTP1 B inhibition improved migration activity of RPE cells.Treatment with AG1478 and PD98059 abolished si RNA-PTP1B-induced activation of EGFR and ERK, α-SMA expression and cell migration.·CONCLUSION: PTP1 B inhibition promoted myofibroblast differentiation and migration of ARPE-19 cells, and EGFR/ERK signaling pathway played important role in migration process. 展开更多
关键词 蛋白质酷氨酸磷酸酶 1B 网膜的颜料上皮 房间移植 表皮的生长因素受体 细胞外的调整信号的 kinase
下载PDF
Evolution of breast cancer therapeutics: Breast tumour kinase's role in breast cancer and hope for breast tumour kinase targeted therapy 被引量:1
7
作者 Haroon A Hussain Amanda J Harvey 《World Journal of Clinical Oncology》 CAS 2014年第3期299-310,共12页
There have been significant improvements in the detection and treatment of breast cancer in recent decades. However, there is still a need to develop more effective therapeutic techniques that are patient specific wit... There have been significant improvements in the detection and treatment of breast cancer in recent decades. However, there is still a need to develop more effective therapeutic techniques that are patient specific with reduced toxicity leading to further increases in patients' overall survival; the ongoing progress in understanding recurrence, resistant and spread also needs to be maintained. Better understanding of breast cancer pathology, molecular biology and progression as well as identification of some of the underlying factors involved in breast cancer tumourgenesis and metastasis has led to the identification of novel therapeutic targets. Over a number of years interest has risen in breast tumour kinase(Brk) also known as protein tyrosine kinase 6; the research field has grown and Brk has been described as a desirable therapeutic target in relation to tyrosine kinase inhibition as well as disruption of its kinase independent activity. This review will outline the current "state of play" with respect to targeted therapy for breast cancer, as well as discussing Brk's role in the processes underlying tumour development and metas-tasis and its potential as a therapeutic target in breast cancer. 展开更多
关键词 BREAST TUMOUR kinase protein tyrosine kinase 6 BREAST neoplasms Targeted molecular therapy Intracellular signaling peptides and proteins protein kinase inhibitors
下载PDF
Current and future treatment of anaplastic lymphoma kinase-rearranged cancer 被引量:1
8
作者 Luca Mologni 《World Journal of Clinical Oncology》 CAS 2015年第5期104-108,共5页
Aberrant forms of the anaplastic lymphoma kinase(ALK) are involved in the pathogenesis of several types of cancer, including anaplastic large cell lymphoma, non-small-cell lung cancer(NSCLC), inflammatory myofibroblas... Aberrant forms of the anaplastic lymphoma kinase(ALK) are involved in the pathogenesis of several types of cancer, including anaplastic large cell lymphoma, non-small-cell lung cancer(NSCLC), inflammatory myofibroblastic tumors, colorectal cancer, neuroblastoma and others. In general, the ALK catalytic domain is rearranged and fused to a dimerization domain encoded by an unrelated gene. Less frequently, full-length ALK is activated by point mutations. The common theme is unregulated firing of ALK downstream signalling, leading to uncontrolled cell division and increased cell survival. ALK-driven tumors can be treated with Crizotinib, an orally available dual ALK/MET inhibitor, currently approved for advanced ALK-positive NSCLCs. Crizotinibtreated patients achieve high response rates, with an excellent toxicity profile. However, drug-resistant disease often develops, particularly in NSCLC patients. The processes leading to drug resistance include both ALKdependent(point mutations or gene amplification), as well as ALK-independent mechanisms, which are here briefly discussed. Recently, Ceritinib has been approved for Crizotinib-refractory NSCLC, further extending patients' survival, but resistance again emerged. Novel ALK kinase inhibitors are currently under clinical development, showing great promise for improved efficacy in drugresistance disease. It is opinion of the author that drugresistance is likely to arise under any treatment, due to intrinsic heterogeneity and adaptability of cancer. To prevent or delay this phenomenon, we need to treat less advanced disease, with drugs that are rapidly effective in order not to allow enough time for tumor evolution, and we want to have more and more drugs with nonoverlapping resistance profiles, for subsequent lines of targeted therapy. Finally, the use of drug combinations may exponentially decrease the chances of resistance. 展开更多
关键词 ANAPLASTIC lymphoma kinase tyrosine kinase receptor protein kinase inhibitors DRUG resistance CRIZOTINIB DRUG COMBINATIONS
下载PDF
Effect of quercetin on activities of protein kinase C and tyrosine protein kinase from HL-60 cells 被引量:28
9
作者 康铁邦 梁念慈 《中国药理学报》 CSCD 1997年第4期374-376,共3页
目的:研究槲皮素(Que)对HL60细胞中细胞溶质和胞膜蛋白激酶C(PKC)、酪氨酸蛋白激酶(TPK)活性的影响.方法:活细胞数的计数用苔盼兰拒染法;用组蛋白ⅢS、[γ32P]ATP与PKC酶液一起保温测定PKC... 目的:研究槲皮素(Que)对HL60细胞中细胞溶质和胞膜蛋白激酶C(PKC)、酪氨酸蛋白激酶(TPK)活性的影响.方法:活细胞数的计数用苔盼兰拒染法;用组蛋白ⅢS、[γ32P]ATP与PKC酶液一起保温测定PKC活性;用聚谷氨酸·酪氨酸(4∶1)多肽)、[γ32P]ATP与TPK酶液一起保温测定TPK活性.结果:Que对HL60细胞的增殖有抑制作用,呈剂量依赖关系,处理48小时后,其IC50为29(22-37)μmol·L-1;在体外,Que能强烈抑制细胞溶质PKC和胞膜TPK活性,其IC50分别为:31(20-48)μmol·L-1,24(13-45)μmol·L-1,但不影响胞膜PKC和细胞溶质TPK活性.结论:这为Que对癌细胞的生长有抑制作用与其抑制PKC和/或TPK有关提供了直接证据. 展开更多
关键词 HL-60细胞 槲皮素 蛋白激酶C 酪氨酸
原文传递
Treatment time influences the effects of a low-frequency pulsed electric field on synthesis of tyrosine hydroxylase and dopamine in PC12 cells
10
作者 Hongfeng Zhang Yuanzhang Fang +1 位作者 Ying Liu Hongxing Qi 《Neural Regeneration Research》 SCIE CAS CSCD 2010年第4期291-294,共4页
BACKGROUND:Electromagnetic radiation can influence dopamine(DA) synthesis in brain tissues or cells,but electromagnetic frequencies,intensities,and radiation time can produce different effects.In addition,the signal p... BACKGROUND:Electromagnetic radiation can influence dopamine(DA) synthesis in brain tissues or cells,but electromagnetic frequencies,intensities,and radiation time can produce different effects.In addition,the signal pathway by which electromagnetic radiation influences DA synthesis remains controversial.OBJECTIVE:To determine tyrosine hydroxylase(TH) expression in PC12 cells and DA levels in cell culture media after different periods of low-frequency pulsed electric field(LF-PEF) stimulation,and to determine how LF-PEF signaling stimulates TH synthesis using inhibitors.DESIGN,TIME AND SETTING:A parallel,controlled,cell experiment was performed at the Laboratory of Cell Biology,School of Life Science,East China Normal University,between January and October 2006.MATERIALS:PC12 cells were purchased from the Shanghai Institute of Biochemistry and Cell Biology,Chinese Academy of Sciences,China.Nerve growth factor was purchased from PeproTech,USA.The protein kinase A inhibitor,H-89,and mitogen-activated protein kinase kinase inhibitor,U0126,were purchased from Sigma,USA.METHODS:(1) Following routine culture in Dulbecco's modified eagle medium,primary PC12 cells were stimulated under LF-PEF(pulse frequency 50 Hz,pulse width 20 μs,peak field strength 1 V/m) for 5,10,15,20,and 30 minutes.(2) Inhibitors(H-89 or U0126,1 μmol/L) were added 30 minutes before LF-PEF stimulation for 10 minutes.MAIN OUTCOME MEASURES:(1) TH expression was determined by Western blot in PC12 cells at 0.5,1,2,3,and 4 days after LF-PEF stimulation.Similarly,DA was measured by high-performance liquid chromatography in media at 2,3,4,or 5 days after LF-PEF.(2) TH expression was detected 1 day after H-89 or U0126 treatment and LF-PEF.RESULTS:(1) Short-term LF-PEF stimulation(5 and 10 minutes) increased TH expression and media DA levels after short-term culture(2 days)(P<0.01),but both parameters decreased with longer culture(3-4 days)(P<0.01).Long-term LF-PEF stimulation(15,20,or 30 minutes) decreased TH and DA synthesis,followed by a rapid increase(P<0.01).(2) H89 could completely inhibit TH expression in PC12 cells stimulated by LF-PEF for 10 minutes,while the inhibition rate of U0126 was 53.2%.CONCLUSION:Short-term LF-PEF first promotes then inhibits,while long-term LF-PEF first inhibits then promotes,TH and DA synthesis.LF-PEF stimulation regulates TH expression primarily by activating protein kinase A to regulate DA synthesis. 展开更多
关键词 low-frequency pulsed electric field PC12 cells tyrosine hydroxylase DOPAMINE protein kinase A pathway Ras/mitogen-activated protein kinase kinase 1/2 pathway
下载PDF
Recent advances in the molecular mechanism of Janus kinase activation
11
作者 Yukun Han Jianliang Zhang 《Journal of Translational Neuroscience》 2018年第4期15-20,共6页
The JAK (Janus kinase) family members play a role in the transmission of signals from extracellular stimuli across the plasma membrane via the cytoplasm to the nucleus in eukaryotes. The JAK family is comprised of JAK... The JAK (Janus kinase) family members play a role in the transmission of signals from extracellular stimuli across the plasma membrane via the cytoplasm to the nucleus in eukaryotes. The JAK family is comprised of JAK1, JAK2, JAK3 and TYK2 (tyrosine kinase 2), and the complexities underlying their activation and regulation are still being investigated. Here, we review the recent advances of their functions and the underlying mechanism of activation. At the molecular level, recent studies have greatly advanced our knowledge of the structures and organization of the JAK proteins, as well as the mechanism of JAK activation, particularly the role of the pseudokinase domain as a suppressor of the adjacent tyrosine kinase domain’s catalytic activity. We also review recent advances in our understanding of the mechanisms of negative regulation exerted by phosphatase and SH2 (Src homology 2) domain-containing proteins. These recent studies highlight the diversity of regulatory mechanisms utilized by the JAK family to maintain signalling fidelity, and shed much light on the potential novel strategies for precise treatment of the associated diseases. 展开更多
关键词 Janus kinase (JAK) NEUROINFLAMMATION non-receptor tyrosine kinaseS NEURODEGENERATION
下载PDF
Role of protein tyrosine kinase in IL-1β induced activation of mitogen- activated protein kinase in fibroblast-like synoviocytes of rheumatoid arthritis 被引量:6
12
作者 吕厚山 孙铁铮 +1 位作者 药立波 张育军 《Chinese Medical Journal》 SCIE CAS CSCD 2000年第10期8-12,共5页
Obejctives To study mitogen activated protein kinase (MAPKs) activation in fibroblast like synoviocytes (FLS) of rheumatoid arthritis (RA) under the stimulation of IL 1β, and to elucidate the role of protein tyrosine... Obejctives To study mitogen activated protein kinase (MAPKs) activation in fibroblast like synoviocytes (FLS) of rheumatoid arthritis (RA) under the stimulation of IL 1β, and to elucidate the role of protein tyrosine kinase (PTK) in the activation of MAPKs Methods Primary cultures of RA FLS were used Western blot was applied to examine transient changes in protein tyrosine phosphorylation status and MAPKs activation in RA FLS stimulated with IL 1β at various doses, and over different periods Genistein, the specific PTK inhibitor, was used to evaluate the inhibitory role in activation of MAPKs by IL 1β Results IL 1β transiently increased protein tyrosine phosphorylation, and activated the MAPKs cascades (mainly ERK 2, JNK 2 and P 38 ) in RA FLS There was no obvious difference in MAPKs activation among different doses of IL 1β (1?IU/ml,10?IU/ml, 100?IU/ml), but the peak activation of ERK 2, JNK 2 and P 38 took place at 5?min, 15?min and 1?min, respectively, after stimulation with IL 1β The activation of ERK 2 was inhibited by genistein, but the inhibitory role on that of JNK and P 38 was relatively weak Conclusions During signal transduction of IL 1β in RA FLS, tyrosine phosphorylation was increased transiently, the MAPKs cascade was activated in a few minutes, and there was heterogenicity in the activation among three subfamily members PTK had a role in the activation of ERK, but had weak effects on that of JNK and P 展开更多
关键词 arthritis · FIBROBLASTS · IL 1 beta · MITOGEN ACTIVATED protein kinase · protein tyrosine kinase · genistein
原文传递
慢性肾小球肾炎患者MCP-1和sFlt-1表达与肾功能及预后的相关性研究
13
作者 韩霞 夏丽华 《微循环学杂志》 2024年第1期48-52,57,共6页
目的:分析慢性肾小球肾炎患者血清单核细胞趋化蛋白-1(MCP-1)和可溶性血管内皮细胞生长因子受体1(sFlt-1)水平变化及其与肾功能和预后的关系。方法:纳入2018-01—2020-03本院收治的慢性肾小球肾炎患者122例(研究组),选取同时期本院体检... 目的:分析慢性肾小球肾炎患者血清单核细胞趋化蛋白-1(MCP-1)和可溶性血管内皮细胞生长因子受体1(sFlt-1)水平变化及其与肾功能和预后的关系。方法:纳入2018-01—2020-03本院收治的慢性肾小球肾炎患者122例(研究组),选取同时期本院体检健康者128例(对照组)。研究组依据肾功能损害情况分为A组(肾功能正常16例)、B组(轻中度肾功能损害88例)、C组(重度肾功能损害18例);根据随访结局,将患者分为肾功能衰竭组(22例)和病情缓解组(100例)。采用酶联免疫吸附法(ELISA)检测受试者MCP-1、sFlt-1水平。采用全自动生化分析仪检测所有受试者血尿素氮(BUN)、血肌酐(Scr)水平,采用慢性肾脏疾病流行病学合作研究公式(CKD-EPI)估算肾小球滤过率(eGFR)。Pearson法分析MCP-1、sFlt-1与BUN、Scr、eGFR的相关性。采用受试者工作特征(ROC)曲线评价血清MCP-1、sFlt-1水平预测慢性肾小球肾炎患者预后的价值。结果:与对照组相比,研究组MCP-1、sFlt-1、BUN、Scr水平较高(P<0.05),eGFR较低(P<0.05)。C组BUN、Scr、MCP-1、sFlt-1水平明显高于A组、B组(P<0.05),B组BUN、Scr、MCP-1、sFlt-1水平明显高于A组(P<0.05)。Pearson相关性分析显示,MCP-1与BUN、Scr均呈正相关(P<0.05),与eGFR呈负相关(P<0.05),sFlt-1与BUN、Scr均呈正相关(P<0.05),与eGFR呈负相关(P<0.05)。与病情缓解组相比,肾功能衰竭组患者清中MCP-1、sFlt-1水平较高(P<0.05)。ROC分析显示,血清MCP-1、sFlt-1水平预测慢性肾小球肾炎患者预后的AUC分别为0.967、0.965,MCP-1联合sFlt-1预测慢性肾小球肾炎患者预后的AUC为0.984,灵敏度100.00%,特异度94.00%。结论:慢性肾小球肾炎患者血清MCP-1、sFlt-1水平明显上升,可作为患者预后评估的潜在生物学指标。 展开更多
关键词 肾小球滤过率 单核细胞趋化蛋白1 可溶性血管内皮细胞生长因子受体1 慢性肾小球肾炎 预后
下载PDF
西藏地区结直肠癌免疫治疗和靶向治疗相关分子标志物的检测及意义
14
作者 罗含欢 刘斌云 +7 位作者 霍真 边巴扎西 王倩 多布啦 尼玛卓玛 达珍 王寒 郭平平 《中国医学科学院学报》 CAS CSCD 北大核心 2024年第2期184-192,共9页
目的研究西藏地区结直肠癌中SWI/SNF相关、基质相关、肌动蛋白依赖性染色质调节因子A亚科成员4(SMARCA4)/Brahma相关基因1、V-raf鼠类肉瘤病毒癌基因同源物B(BRAF)、P53、程序性死亡受体1(PD-1)及程序性死亡配体1(PD-L1)免疫组织化学表... 目的研究西藏地区结直肠癌中SWI/SNF相关、基质相关、肌动蛋白依赖性染色质调节因子A亚科成员4(SMARCA4)/Brahma相关基因1、V-raf鼠类肉瘤病毒癌基因同源物B(BRAF)、P53、程序性死亡受体1(PD-1)及程序性死亡配体1(PD-L1)免疫组织化学表达和BRAF、神经营养因子酪氨酸受体激酶(NTRK)基因改变情况,为西藏地区结直肠癌患者的靶向治疗及免疫治疗提供依据。方法收集2015年1月至2021年7月西藏自治区人民医院经手术切除病理确诊为结直肠癌病例64例,全部病例均进行SMARCA4、BRAF、P53、PD-1、PD-L1免疫组织化学染色和NTRK1、NTRK2、NTRK3融合基因荧光原位杂交检测及BRAF V600E基因突变PCR检测。结果64例结直肠癌病例男女比例1.21∶1,平均年龄(56.59±13.27)岁;46例(71.88%)位于结肠,18例(28.12%)位于直肠;60例(93.75%)为腺癌,4例(6.25%)为其他类型;11例(17.19%)为T1或T2期,53例(82.81%)为T3或T4期;24例(37.50%)出现淋巴结转移。免疫组织化学方面,64例中1例(1.56%)SMARCA4部分肿瘤细胞表达减弱或缺失,4例(6.25%)BRAF肿瘤细胞阳性表达,35例(54.69%)P53为突变型表达;45例(70.31%)PD-1肿瘤相关免疫细胞阳性比例分数<10%,19例(29.69%)≥10%;52例(81.25%)PD-L1联合阳性分数<10,12例(18.75%)≥10。64例NTRK1、NTRK2、NTRK3融合基因检测均为阴性;4例(6.25%)检测到BRAF V600E基因突变;1例SMARCA4表达缺失病例未检测到SMARCA4基因改变。PD-L1的表达与错配修复缺陷/高度微卫星不稳定和PD-1的高表达呈显著正相关(χ^(2)=10.223,P=0.001;χ^(2)=11.979,P=0.001)。结论西藏地区结直肠癌中较少出现SMARCA4表达减弱或缺失及NTRK融合基因改变,少数病例有BRAF V600E基因突变,Pan-TRK和BRAF免疫组织化学可作为NTRK融合基因及BRAF基因突变的初筛方法。错配修复缺陷/高度微卫星不稳定的病例中更容易出现PD-L1蛋白高表达,这部分患者有望获益于免疫治疗。P53突变与PD-L1表达无相关性,PD-1的高表达和PD-L1的高表达呈正相关。 展开更多
关键词 西藏地区 结直肠癌 SWI/SNF相关、基质相关、肌动蛋白依赖性染色质调节因子A亚科成员4 程序性死亡受体1 程序性死亡配体1 V-raf鼠类肉瘤病毒癌基因同源物B 神经营养因子酪氨酸受体激酶
下载PDF
Mechanism involved in the modulation of photoreceptor-specific cyclic nucleotidegated channel by the tyrosine kinase adapter protein Grb14 被引量:1
15
作者 Vivek K.Gupta Ammaji Rajala +1 位作者 Karla K.Rodgers Raju V.S.Rajala 《Protein & Cell》 SCIE CSCD 2011年第11期906-917,共12页
We recently found that growth factor receptor-bound(Grb)protein 14 is a novel physiological modulator of photoreceptor specific cyclic nucleotide-gated channel alpha subunit(CNGA1).Grb14 promotes the CNG channel closu... We recently found that growth factor receptor-bound(Grb)protein 14 is a novel physiological modulator of photoreceptor specific cyclic nucleotide-gated channel alpha subunit(CNGA1).Grb14 promotes the CNG channel closure through its Ras-associating(RA)domain.In the current study we show that this RA domain-mediated inhibition of rod CNG channel is electrostatic in nature.Grb14 competes with cGMP for the CNGA1 binding pocket and electrostatically interacts with Arg^(559) through a negatively chargedβ-turn at its RA domain.Moreover,the three Glu residues(180–182)in Grb14 are absolutely critical for electrostatic interaction with the cGMP binding pocket and resultant inhibition.Our study also demonstrates that substitution of Lys^(140) for Ala or in combination with polyglutamte mutants of Grb14 results in a significantly reduced binding with CNGA1.These results suggest that in addition to Glu^(180–182) and Lys^(140),other residues in Grb14 may be involved in the electrostatic interaction with CNGA1.The RA domain is highly conserved among the members of Grb7 family of proteins,which includes Grb7,Grb10 and Grb14.Further,only Grb14 is able to modulate the channel activity,but not Grb7 and Grb10.All together,it suggests the existence of a divergence in RA domains among the members of the Grb7 family. 展开更多
关键词 growth factor receptor-bound protein 14(Grb14) Ras-associating domain cyclic nucleotide gated channel rod outer segments tyrosine kinase signaling
原文传递
神经生长因子及其受体在高原牦牛与平原黄牛端脑中的比较分析
16
作者 吴亚娟 杜晓华 +2 位作者 刘霞 郑丽平 刘珊珊 《核农学报》 CAS CSCD 北大核心 2024年第2期265-273,共9页
为探究神经生长因子(NGF)及其高亲和力受体酪氨酸蛋白激酶A(TrkA)在高原牦牛(Bos grunniens)与平原黄牛(Bos taurus)端脑组织中表达与分布的差异,本研究采集不同海拔地区的成年牦牛与黄牛端脑不同组织(n=5),利用免疫组织化学技术(IHC)... 为探究神经生长因子(NGF)及其高亲和力受体酪氨酸蛋白激酶A(TrkA)在高原牦牛(Bos grunniens)与平原黄牛(Bos taurus)端脑组织中表达与分布的差异,本研究采集不同海拔地区的成年牦牛与黄牛端脑不同组织(n=5),利用免疫组织化学技术(IHC)、实时荧光定量PCR(qRT-PCR)以及蛋白免疫印迹技术(WB)对NGF和TrkA在牦牛与黄牛端脑各区中的定位特征及表达水平进行比较。IHC结果显示,两种因子在牦牛与黄牛端脑各区中的分布与定位特征基本一致,主要在神经元胞质、神经胶质细胞及血管内壁中表达,其蛋白免疫阳性反应强度整体表现为牦牛高于黄牛。qRT-PCR结果显示,牦牛的NGF基因表达量在额叶皮质、大脑白质及枕叶皮质中低于黄牛或无差异,在其余区域中显著高于黄牛(P<0.05);TrkA基因表达量仅在大脑白质中与黄牛无显著差异,其余区域中显著高于黄牛(P<0.05)。WB结果显示,牦牛的NGF蛋白表达量仅在大脑白质中低于黄牛,其余区域均显著高于黄牛(P<0.05);牦牛的TrkA蛋白表达量在额叶皮质、大脑白质及枕叶皮质中低于黄牛或无差异,其余区域中显著高于黄牛(P<0.05)。综上,两种因子在牦牛端脑部分组织表达上调可能与低氧刺激有关,推测二者在低氧条件下协同发挥内源性神经保护作用,以维持动物机体正常的生理活动。本研究结果为进一步探究NGF和TrkA在牦牛低氧适应性方面发挥作用提供了理论依据。 展开更多
关键词 神经生长因子 酪氨酸蛋白激酶A 牦牛 端脑
下载PDF
基于网络药理学和分子对接的白藜芦醇治疗口腔鳞状细胞癌的机制研究
17
作者 陈虹君 雷奇 +3 位作者 王治林 钟晓武 邱亚 李丽华 《口腔疾病防治》 2024年第3期178-187,共10页
目的通过网络药理学及分子对接等生物学信息方法,探讨白藜芦醇治疗口腔鳞状细胞癌(oral squamous cell carcinoma,OSCC)的分子机制,为白藜芦醇治疗OSCC的临床应用提供参考。方法利用Swiss Target Prediction(http://www.swisstargetpred... 目的通过网络药理学及分子对接等生物学信息方法,探讨白藜芦醇治疗口腔鳞状细胞癌(oral squamous cell carcinoma,OSCC)的分子机制,为白藜芦醇治疗OSCC的临床应用提供参考。方法利用Swiss Target Prediction(http://www.swisstargetprediction.ch)、SEA数据库(http://sea.bkslab.org)、Pharm mapper数据库(http://lilab-ecust.cn)检索获得白藜芦醇的相关靶点,以DISGENET(www.disgenet.org)、OMIM(https://omim.org)、GeneCards(https://www.genecards.org)数据库筛选OSCC疾病靶点,取药物与疾病靶点的交集,再采用Cytoscape 3.7.2软件构建“药物-疾病-靶点-通路”网络,String数据库构建靶蛋白相互作用网络,采用DAVID数据库对关键蛋白进行富集分析,最后通过AutoDock及PyMOL对关键蛋白进行分子对接验证,结合富集分析和分子对接结果预测白藜芦醇治疗OSCC可能的分子作用机制;细胞水平采用Western blot检测不同浓度(50、100μmol/L)白藜芦醇对OSCC细胞株HSC-3细胞Src酪氨酸激酶(Src tyro-sine kinase,SRC)、表皮生长因子受体(epidermal growth factor receptor,EGFR)、雌激素受体基因1(estrogen receptor gene 1,ESR1)及磷脂酰肌醇三激酶/蛋白激酶B(phosphatidylinositol 3 kinase/protein kinase B,PI3K/AKT)信号通路蛋白表达的影响。结果数据库得到白藜芦醇药物靶点243个,OSCC疾病靶点6094个,将药物与疾病的靶点进行交集获得116个潜在靶点,潜在靶点主要集中参与体内蛋白质自磷酸化、肽基酪氨酸磷酸化、跨膜受体蛋白酪氨酸激酶信号通路、RNA聚合酶Ⅱ启动子转录的正调控等生物过程,干预PI3K/AKT信号通路发挥抗OSCC的作用。分子对接结果表明白藜芦醇与EGFR、ESR1、SRC等OSCC关键靶点具有较好的结合活性。细胞实验结果表明,白藜芦醇药物干预以剂量依赖的方式抑制了HSC-3细胞中SRC、EGFR、ESR1及p-PI3K和p-AKT的蛋白表达。结论白藜芦醇对OSCC细胞SRC、EGFR、ESR1、p-PI3K、p-AKT靶点具有抑制作用。 展开更多
关键词 白藜芦醇 口腔鳞状细胞癌 网络药理学 分子对接 SRC酪氨酸激酶 表皮生长因子受体 雌激素受体基因1 磷脂酰肌醇三激酶/蛋白激酶B信号通路
下载PDF
机械应力调控血管平滑肌细胞的凋亡
18
作者 徐飞 闫金强 柴守栋 《中国组织工程研究》 CAS 北大核心 2025年第5期1064-1072,共9页
背景:随着生物力学的发展,其在心血管疾病中的研究也日益广泛,通过研究血管的力学特性可以有效地揭示动脉粥样硬化、再狭窄等心血管疾病的发病机制,开发心血管疾病治疗的新思路和新方法。目的:综述机械应力刺激对血管平滑肌细胞凋亡的... 背景:随着生物力学的发展,其在心血管疾病中的研究也日益广泛,通过研究血管的力学特性可以有效地揭示动脉粥样硬化、再狭窄等心血管疾病的发病机制,开发心血管疾病治疗的新思路和新方法。目的:综述机械应力刺激对血管平滑肌细胞凋亡的研究现状,寻找临床治疗潜在靶分子和信号通路,以期改善临床动脉粥样硬化及再狭窄等心血管疾病的临床治疗效果。方法:检索1992年1月至2023年5月在中国知网、PubMed及ScienceDirect数据库收录的文献。中文检索词为“血管平滑肌细胞,机械应力,剪切力,牵张力,凋亡”;英文检索词为“vascular smooth muscle cell,mechanical stress,shear stress,stretch stress,apoptosis”,最终纳入63篇文献进行综述分析。结果与结论:①血管平滑肌细胞的生理性和病理性凋亡都是为了适应血管力学变化而发生的适应性重构。不同部位的平滑肌细胞承受不同的力学刺激,其发病机制也不同。②低剪切力、生理剪切力和高剪切力可通过直接与平滑肌细胞表面分子、受体及蛋白等作用调控凋亡信号分子和抑制增殖实现对血管平滑肌细胞凋亡的调控,该部分未对促进增殖的研究进行综述。③低牵张力、生理牵张力和高牵张力可导致平滑肌细胞凋亡,但仍存在争议。平滑肌表面存在多种力学感受分子(如整合素及受体络氨酸激酶等)可以将力学信号转导为细胞内的化学信号(如Hippo通路),启动平滑肌细胞的凋亡信号,调控平滑肌细胞的凋亡。④总之,不同力学刺激通过多种信号分子,启动多个信号通路共同作用,调控平滑肌细胞的凋亡,例如剪切力主要通过刺激分泌前列腺素、转化生长因子等影响Fas/FasL、Akt通路;而牵张力主要通过Yes相关蛋白等调控YAP通路和Notch通路等。这些分子在不同的作用时间,或不同作用强度下可能发挥相反的双向作用,比如,小鼠血管平滑肌细胞受到10%生理牵张1 h时,其增殖增加;然而,人的血管平滑肌细胞牵张12 h后可以减少其增殖。临床可以通过寻找其关键作用时间点干扰力学转导关键分子,达到预防和治疗临床心血管疾病的目的。 展开更多
关键词 血管平滑肌细胞 机械应力 凋亡 牵张力 剪切应力 整合素 受体络氨酸激酶 G蛋白偶联受体和G蛋白 离子通道
下载PDF
MiR-28-5p靶向DOK4对口腔鳞状细胞癌细胞增殖的影响
19
作者 魏校通 闫威 +2 位作者 陈勇 田志峥嵘 赵凤云 《临床肿瘤学杂志》 CAS 2024年第1期22-30,共9页
目的探讨微小RNA(miR)-28-5p通过靶向酪氨酸激酶下游蛋白4(DOK4)对口腔鳞状细胞癌细胞增殖的调控作用。方法下载癌症基因组图谱(TCGA)口腔癌数据库,分析miR-28-5p、DOK4与口腔鳞状细胞癌临床表型的关系;转染miR-28-5p模拟物(mimics)、mi... 目的探讨微小RNA(miR)-28-5p通过靶向酪氨酸激酶下游蛋白4(DOK4)对口腔鳞状细胞癌细胞增殖的调控作用。方法下载癌症基因组图谱(TCGA)口腔癌数据库,分析miR-28-5p、DOK4与口腔鳞状细胞癌临床表型的关系;转染miR-28-5p模拟物(mimics)、miR-28-5p抑制剂(inhibitor)及对照物(NC)、pcDNA3.1-DOK4及空载体(Vector)、DOK4干扰序列(siDOK4)。CCK-8法和克隆集落形成实验检测口腔鳞状细胞癌的细胞增殖能力;检测各组细胞的抗氧化能力和细胞活性氧(ROS)含量;双荧光素酶报告基因实验验证miR-28-5p与DOK4的靶向关系;观察DOK4过表达对细胞增殖和口腔鳞状细胞癌裸鼠移植瘤生长的影响。结果生物信息学分析显示,相较于癌旁口腔组织,miR-28-5p在口腔鳞状细胞癌组织中表达上调,DOK4 mRNA下调(P<0.05);临床分期Ⅳ期、M 1期、G 3~G 4分级患者miR-28-5p水平高于临床分期Ⅰ~Ⅲ期、M 0期、G 1~G 2分级者(P<0.05);临床分期Ⅳ期、N 1期、G_(3)~G_(4)分级患者DOK4 mRNA水平低于临床分期Ⅰ~Ⅲ期、N 0期、G_(1)~G_(2)分级者(P<0.05);DOK4高表达组无进展生存期和总生存期均高于DOK4低表达组(P<0.05)。与miR-NC组比较,miR-28-5p inhibitor组miR-28-5p水平、细胞活性和集落形成数降低(P<0.05)。与miR-NC组比较,miR-28-5p mimics组DOK4 mRNA和蛋白表达水平降低(P<0.05);与Vector组比较,DOK4过表达组细胞和移植瘤组织中DOK4 mRNA和蛋白表达升高,细胞活性、集落形成数、肿瘤体积及重量降低(P<0.05);与miR-28-5p inhibitor组比较,miR-28-5p inhibitor+siDOK4组的DOK4 mRNA和蛋白表达水平降低,细胞增殖活性、集落形成数、还原型烟酰胺腺嘌呤二核苷酸/烟酰胺腺嘌呤二核苷酸(NADPH/NADP+)、谷胱甘肽/氧化性谷胱甘肽(GSH/GSSG)升高,ROS含量降低(P<0.05)。结论miR-28-5p在口腔鳞状细胞癌中表达上调,通过靶向抑制DOK4表达,降低ROS水平,促进细胞增殖。 展开更多
关键词 口腔鳞状细胞癌 增殖 微小RNA-28-5p 酪氨酸激酶下游蛋白4 活性氧
下载PDF
海马过表达Ephrin-B3对颞叶癫痫大鼠突触重塑的影响
20
作者 李莉莉 刘田田 +1 位作者 张敏 刘恒方 《中国实用神经疾病杂志》 2024年第3期265-270,共6页
目的探讨海马内过表达酪氨酸蛋白激酶B3(Ephrin-B3)对大鼠癫痫突触重塑的可能作用机制。方法将40只雄性SD大鼠随机分为空白对照组、癫痫组、空载体组、慢病毒Efnb3过表达组,每组10只。除空白组外,其余3组均进行癫痫造模处理,造模前1周... 目的探讨海马内过表达酪氨酸蛋白激酶B3(Ephrin-B3)对大鼠癫痫突触重塑的可能作用机制。方法将40只雄性SD大鼠随机分为空白对照组、癫痫组、空载体组、慢病毒Efnb3过表达组,每组10只。除空白组外,其余3组均进行癫痫造模处理,造模前1周空载体组两侧海马各注射LV5-NC(5μL)载体,慢病毒过表达组海马注射包装后的Efnb3慢病毒(5μL)进行预处理。观察各组大鼠行为学变化,癫痫造模达24 h后各组取海马组织,采用qPCR检测Ephrin-B3、突触后密度蛋白95(PSD95)、离子型谷氨酸受体亚基(NR2B)的mRNA相对表达变化,蛋白质印迹法检测Ephrin-B3、PSD95、NR2B的蛋白相对表达量。结果Ephrin-B3过表达组癫痫发作潜伏期(30.2±4.38)min,较癫痫组(22.4±3.91)min和空载体组(21.0±5.29)min有所延长(P<0.05),癫痫组和空载体组造模后Ephrin-B3、PSD95、NR2B的mRNA表达量降低,转染Ephrin-B3成功组mRNA相对表达量相较于癫痫模型组明显增加(Ephrin-B3:F=25.11,P=0.0027;PSD95:F=14.80,P=0.0203;NR2B:F=19.51,P=0.0010),相较于空载体注射组亦明显增加(Ephrin-B3:P=0.0029;PSD95:P=0.0160;NR2B:P=0.0034);转染Ephrin-B3成功组相较于癫痫模型组蛋白相对表达量增加(Ephrin-B3:F=17.72,P=0.0032;PSD95:F=7.889,P=0.0145;NR2B:F=9.755,P=0.0199),较空载体注射组表达亦明显增加(Ephrin-B3:P=0.0034;PSD95:P=0.0253;NR2B:P=0.0144)。结论过表达Ephrin-B3可减轻癫痫发作损伤,其机制可能与调控突触后蛋白PSD95、NR2B的表达量控制突触重塑有关。 展开更多
关键词 颞叶癫痫 酪氨酸蛋白激酶B3 突触后密度蛋白95 离子型谷氨酸受体 新生神经元 突触重塑
下载PDF
上一页 1 2 47 下一页 到第
使用帮助 返回顶部